Furthermore, the absence of PDLIM2 significantly augments the malignant behavior of NSCLC cells, and reduced expression levels are associated with poor patient survival in lung cancer (Baker et al., 2011). This evidence concerns the gene PDLIM2 and lung carcinoma.